Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
Covid-19 roundup: Catalent lends vaccine production capacity to AstraZeneca/Oxford for hundreds of millions doses
5 years ago
Financing
Eli Lilly launches PhIII JAK study, aiming for the first drug to lower mortality in Covid-19
5 years ago
R&D
Sinovac posts positive PhI/II data for their Covid-19 vaccine as researchers rush into a pivotal test
5 years ago
R&D
Moderna burnishes its PhIII-ready Covid-19 vaccine with promising mouse data — which suggest one dose might be enough after all
5 years ago
R&D
Covid-19 roundup: China's Sinovac goes to Brazil for PhIII; AstraZeneca signs Emergent on for $87M manufacturing deal
5 years ago
FDA weighs post-pandemic challenges at BIO meeting
5 years ago
FDA+
Moderna floors it into PhIII with their Covid-19 vaccine, planning quick start with a thumbs-up from FDA on trial design, dosage
5 years ago
R&D
Covid-19 roundup: Regeneron puts its antibodies into the clinic, racing with Eli Lilly for fall authorization
5 years ago
Peter Marks dishes on Covid-19 vaccine development at BIO
5 years ago
FDA+
Covid-19 roundup: Fauci talks pricing, disparate impact and the virus’s enduring mysteries; China to offer experimental vaccines to overseas workers
5 years ago
R&D
Covid-19 roundup: Europe is ‘weeks away’ from remdesivir decision; John Farley gets permanent gig as chief of FDA division steering pandemic response
5 years ago
Covid-19 roundup: Yet more doses of the AstraZeneca-Oxford vaccine; A second randomized hydroxychloroquine study fails
5 years ago
Covid-19 roundup: AbbVie jumps into Covid-19 antibody hunt; AstraZeneca shoots for 2B doses of Oxford vaccine — with $750M from CEPI, Gavi
5 years ago
Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead
5 years ago
Covid-19 roundup: Moderna readies to enter PhIII in July, AstraZeneca not far behind; EU ready to negotiate vaccine access with $2.7B fund
5 years ago
White House names finalists for Operation Warp Speed — with 5 expected names and one notable omission
5 years ago
Estimating a US price tag of $5K per course, remdesivir is set to make billions for Gilead, says key analyst
5 years ago
R&D
Pharma
Cameron Durrant hustled his way from the OTC sidelines right into the Covid-19 drug race. Death or glory lies straight ahead
5 years ago
People
Bioregnum
Covid-19 roundup: BARDA supports Operation Warp Speed with big $628M contract to service America's vaccine production needs
5 years ago
Stephen Hahn: FDA will make some changes amid Covid-19 permanent
5 years ago
FDA+
Covid-19 roundup: Did insiders cash in on positive news report about Gilead before publication?
5 years ago
Novartis jumps into Covid-19 vaccine hunt, as Big Pharma and big biotech commit to billions of doses
5 years ago
Covid-19 roundup: FDA's Stephen Hahn personally helped a doctor set up hydroxychloroquine trial — report
5 years ago
FDA explains impact of Covid-19 on applications, formal meetings
5 years ago
FDA+
First page
Previous page
49
50
51
52
53
54
55
Next page
Last page